Immediate Impact
1 by Nobel laureates 74 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients
2024 Standout
Works of César Augusto Ramírez being referenced
CAR-T Cell Performance: How to Improve Their Persistence?
2022
Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| César Augusto Ramírez | 76 | 71 | 97 | 109 | 81 | 22 | 311 | |
| Norihiko Akamatsu | 15 | 85 | 60 | 39 | 141 | 31 | 365 | |
| Bingzheng Shen | 19 | 47 | 116 | 40 | 49 | 23 | 345 | |
| Fengyan Pei | 17 | 71 | 86 | 27 | 28 | 19 | 339 | |
| Elisabetta Ugolotti | 59 | 62 | 102 | 28 | 94 | 33 | 343 | |
| B. Delaere | 70 | 160 | 28 | 36 | 18 | 19 | 313 | |
| Mohammad Mehdi Aslani | 29 | 49 | 104 | 23 | 35 | 33 | 328 | |
| Parastoo Hosseini | 17 | 62 | 71 | 15 | 37 | 20 | 331 | |
| Nadia Keller | 115 | 55 | 102 | 17 | 98 | 14 | 338 | |
| Grażyna Braś | 24 | 71 | 59 | 44 | 26 | 20 | 282 | |
| Khalid Ahmed Al‐Anazi | 25 | 138 | 76 | 62 | 23 | 31 | 350 |
All Works
Login with ORCID to disown or claim papers
Loading papers...